The cyclophilin-binding agent sanglifehrin a is a dendritic cell chemokine and migration inhibitor

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Immecke, Sabrina N ^a   Baal, Nelli ^a   Wilhelm, Jochen ^a   Bechtel, Juliane ^a   Knoche, Angela ^a   Bein, Gregor ^a   Hackstein, Holger ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CXCL9 CHEMOKINE; CYCLOPHILIN A; CYCLOSPORIN A; DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; SANGLIFEHRIN A; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CCR7 PROTEIN, HUMAN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CYCLOPHILIN; CYTOKINE; LACTONE; SPIRO COMPOUND;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; LYMPHOCYTE MIGRATION; MIGRATION INHIBITION; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; DNA MICROARRAY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; METABOLISM; PROTEIN BINDING;

ANIMALS; ANTIGENS, CD38; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; CYCLOPHILINS; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LACTONES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; RECEPTORS, CCR7; SPIRO COMPOUNDS;

EID: 79953646676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018406     Document Type: Article

References (37)

1. Sanglier JJ, Quesniaux V, Fehr T, Hofmann H, Mahnke M, et al. (1999) Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) 52: 466-473.
2. Fehr T, Kallen J, Oberer L, Sanglier JJ, Schilling W, (1999) Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties. J Antibiot (Tokyo) 52: 474-479.
3. Pemberton TJ, Kay JE, (2003) Cyclophilin sensitivity to sanglifehrin A can be correlated to the same specific tryptophan residue as cyclosporin A. FEBS Lett 555: 335-340.
4. Sedrani R, Kallen J, Martin Cabrejas LM, Papageorgiou CD, Senia F, et al. (2003) Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data. J Am Chem Soc 125: 3849-3859.
5. Zenke G, Strittmatter U, Fuchs S, Quesniaux VF, Brinkmann V, et al. (2001) Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action. J Immunol 166: 7165-7171.
6. Kallen J, Sedrani R, Zenke G, Wagner J, (2005) Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6 A resolution. J Biol Chem 280: 21965-21971 Epub 22005 Mar 21916.
7. Allen A, Zheng Y, Gardner L, Safford M, Horton MR, et al. (2004) The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol 172: 4797-4803.
8. Powell JD, Zheng Y, (2006) Dissecting the mechanism of T-cell anergy with immunophilin ligands. Curr Opin Investig Drugs 7: 1002-1007.
9. Woltman AM, Schlagwein N, van der Koij SW, van Kooten C, (2004) The novel cyclophilin-binding drug Sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells. J Immunol 172: 6482-6489.
10. Steinschulte C, Taner T, Thomson AW, Bein G, Hackstein H, (2003) Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells. J Immunol 171: 542-546.
11. Hackstein H, Steinschulte C, Fiedel S, Eisele A, Rathke V, et al. (2007) Sanglifehrin a blocks key dendritic cell functions in vivo and promotes long-term allograft survival together with low-dose CsA. Am J Transplant 7: 789-798.
12. Ko H, Hambly BD, Eris JM, Levidiotis V, Wyburn K, et al. (2008) Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A. Transpl Immunol 26: 26.
13. Hackstein H, Thomson AW, (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4: 24-34.
14. Steinman RM, Banchereau J, (2007) Taking dendritic cells into medicine. Nature 449: 419-426.
15. Morelli AE, Thomson AW, (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7: 610-621 Epub 2007 Jul 2013.
16. Raimondi G, Turnquist HR, Thomson AW, (2007) Frontiers of immunological tolerance. Methods Mol Biol 380: 1-24.
17. Banchereau J, Klechevsky E, Schmitt N, Morita R, Palucka K, et al. (2009) Harnessing human dendritic cell subsets to design novel vaccines. Ann N Y Acad Sci 1174: 24-32.
18. Lukacs-Kornek V, Engel D, Tacke F, Kurts C, (2008) The role of chemokines and their receptors in dendritic cell biology. Front Biosci 13: 2238-2252.
19. Colvin BL, Matta BM, Thomson AW, (2008) Dendritic cells and chemokine-directed migration in transplantation: where are we headed? Clin Lab Med 28: 375-384, v.
20. Turnquist HR, Fischer RT, Thomson AW, (2010) Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation. Methods Mol Biol 595: 135-148.
21. Hackstein H, Taner T, Logar AJ, Thomson AW, (2002) Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood 100: 1084-1087.
22. Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, et al. (2003) Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101: 4457-4463.
23. Thomson AW, Turnquist HR, Raimondi G, (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9: 324-337.
24. Raimondi G, Sumpter TL, Matta BM, Pillai M, Corbitt N, et al. (2009) Mammalian Target of Rapamycin Inhibition and Alloantigen-Specific Regulatory T Cells Synergize to Promote Long-Term Graft Survival in Immunocompetent Recipients. J Immunol.
25. Khatri P, Sellamuthu S, Malhotra P, Amin K, Done A, et al. (2005) Recent additions and improvements to the Onto-Tools. Nucleic Acids Res 33: W762-765.
26. Fedele G, Frasca L, Palazzo R, Ferrero E, Malavasi F, et al. (2004) CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction. Eur J Immunol 34: 1342-1350.
27. Frasca L, Fedele G, Deaglio S, Capuano C, Palazzo R, et al. (2006) CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 107: 2392-2399.
28. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P, (1987) Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 166: 1654-1667.
29. Partida-Sanchez S, Goodrich S, Kusser K, Oppenheimer N, Randall TD, et al. (2004) Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20: 279-291.
30. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA, (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328: 749-752.
31. Forster R, Davalos-Misslitz AC, Rot A, (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8: 362-371.
32. Hornick P, Rose M, (2006) Chronic rejection in the heart. Methods Mol Biol 333: 131-144.
33. Belperio JA, Ardehali A, (2008) Chemokines and transplant vasculopathy. Circ Res 103: 454-466.
34. Colvin BL, Thomson AW, (2002) Chemokines, their receptors, and transplant outcome. Transplantation 74: 149-155.
35. Mackay CR, (2008) Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol 9: 988-998.
36. Smyth GK, (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor New York Springer pp. 397-420.
37. Scandella E, Men Y, Legler DF, Gillessen S, Prikler L, et al. (2004) CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103: 1595-1601.